Circulating sphingolipids and risk and outcomes of ventricular fibrillation
循环鞘脂与心室颤动的风险和结果
基本信息
- 批准号:10443558
- 负责人:
- 金额:$ 58.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-10 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Admission activityAgeAnimal ExperimentsApoptosisArrhythmiaBiologicalBloodBrainCalendarCarbonCardiopulmonary ResuscitationCell membraneCeramidesCountyDataErythrocyte MembraneErythrocytesEtiologyEventExhibitsFatty AcidsFrequenciesFunctional disorderFutureGenderGenerationsGlycerolHeart ArrestHospitalizationHospitalsHumanIncidenceInvestigationIschemiaKnowledgeLeadLengthLipidsMass Spectrum AnalysisMeasuresMedical emergencyMembraneMembrane LipidsMethodsMolecularOutcomeOxidative StressPalmitic AcidsParamedical PersonnelPathway interactionsPatientsPhospholipidsPlayPopulation ControlPreventionPrognosisProxyPublic HealthReperfusion TherapyResearchResuscitationRiskRisk FactorsRoleSamplingSaturated Fatty AcidsSpecimenSphingolipidsSphingomyelinsSystemTimeVentricular FibrillationWashingtonWorkbasecardiovascular healthdata repositorydisorder riskdrug developmenthigh riskimprovedinsightmortalitynew therapeutic targetnovelpi bondrepositorysudden cardiac death
项目摘要
ABSTRACT
Sudden cardiac arrest due to ventricular fibrillation (VF-SCA) is a major public health concern, and a leading
cause of mortality in the US each year. Even in the setting of the best emergency medical systems,
resuscitation efforts fail in most cases, with over 70% mortality. This application seeks to identify novel
factors, erythrocyte membrane sphingomyelin and ceramide species, associated with 1) incidence of VF-
SCA and 2) resuscitation outcomes following VF-SCA. Emerging evidence from cellular and animal
experiments, and our previous work on membrane fatty acids and VF-SCA, lead us to these hypotheses:
erythrocyte sphingomyelins and ceramides that contain the saturated fatty acid palmitic acid (16:0), are
associated with higher risk of VF-SCA and a lower likelihood of resuscitation after VF-SCA; and erythrocyte
sphingomyelins and ceramides that contain a saturated fatty acid with 20 carbons or more (20:0, 22:0 or
24:0), are associated with lower risk of VF-SCA and a greater likelihood of resuscitation. We take
advantage of the Cardiac Arrest Blood Study Repository (CABS-R), a unique, ongoing, repository of data
and specimens on SCA patients in King County, Washington, and optimized mass spectrometry methods to
investigate the associations of erythrocyte membrane sphingomyelins and ceramides with the risk of
incident VF-SCA (Aim 1) and with resuscitation outcomes following VF-SCA (Aim 2). To maximize the
homogeneity of the SCA outcome, we will limit our investigation to SCA patients found in ventricular
fibrillation by the attending paramedics. We will measure 8 primary (15 total) ceramide and sphingomyelin
species in 4624 existing erythrocyte membrane samples, including 2312 from VF-SCA cases in CABS-R
and 2312 from population controls, frequency- matched to cases on age, gender and calendar year. The
investigation of VF-SCA risk (Aim 1) will be conducted in the 2312 VF-SCA cases from CABS-R and the
2312 population controls. For Aim 2, we will use outcome data on the VF-SCA cases from Aim 1 to
investigate the associations of sphingomyelin and ceramide species with hospital admission, a proxy for
cardiac resuscitation, and with discharge alive from the hospital, a proxy for brain resuscitation. The
associations of these novel lipid species with both VF-SCA incidence and resuscitation outcomes will
provide insight into biological pathways that influence the risk and outcomes of VF-SCA, inform potential
novel prevention efforts and advance research involving treatment of VF-SCA.
摘要
室颤引起的心脏骤停(VF-SCA)是一个主要的公共卫生问题,也是一个主要的
每年在美国导致死亡的原因。即使在最好的急救医疗系统的背景下,
复苏努力在大多数情况下都失败了,死亡率超过70%。这个应用程序试图识别小说
红细胞膜鞘磷脂和神经酰胺与1)室性心动过速的发生有关。
SCA和2)VF-SCA后复苏结果。来自细胞和动物的新证据
实验,以及我们之前关于膜脂肪酸和VF-SCA的工作,让我们得出了以下假设:
含有饱和脂肪酸棕榈酸(16:0)的红细胞鞘磷脂和神经酰胺
与VF-SCA风险较高和VF-SCA后复苏可能性较低相关;以及红细胞
神经鞘磷脂和神经酰胺含有20个碳或更多的饱和脂肪酸(20:0、22:0或
24:0),VF-SCA的风险较低,复苏的可能性较大。我们拿着
心脏骤停血液研究资料库(CABS-R)的优势,这是一个独特的、持续的数据资料库
和华盛顿州金县SCA患者的样本,并优化了质谱学方法
探讨红细胞膜鞘磷脂和神经酰胺与糖尿病发病风险的关系
VF-SCA事件(目标1)和VF-SCA后的复苏结果(目标2)。最大限度地提高
SCA结果的同质性,我们的调查将仅限于在脑室发现的SCA患者
主治医生的纤颤。我们将测量8个初级(总共15个)神经酰胺和鞘磷脂
4624例现有红细胞膜样本中的物种,其中2312例来自CABS-R的VF-SCA病例
来自人口控制的2312人,与年龄、性别和日历年的病例频率相匹配。这个
将对来自CABS-R的2312例VF-SCA病例进行VF-SCA风险调查(目标1)和
控制人口2312人。对于目标2,我们将使用目标1至
研究神经鞘蛋白和神经酰胺与住院的关系,神经酰胺和鞘磷脂的代用指标
心脏复苏,出院后还活着,是脑部复苏的指标。这个
这些新的脂质物种与VF-SCA发生率和复苏结果的相关性将
洞察影响VF-SCA风险和结局的生物学途径,告知潜在
新的预防措施和涉及VF-SCA治疗的先进研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rozenn Lemaitre其他文献
Rozenn Lemaitre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rozenn Lemaitre', 18)}}的其他基金
Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease
循环硫化氢、糖尿病和糖尿病相关的心血管疾病
- 批准号:
10420827 - 财政年份:2022
- 资助金额:
$ 58.25万 - 项目类别:
Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease
循环硫化氢、糖尿病和糖尿病相关的心血管疾病
- 批准号:
10700816 - 财政年份:2022
- 资助金额:
$ 58.25万 - 项目类别:
Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease
血浆鞘脂与亚临床和临床心血管疾病
- 批准号:
10201737 - 财政年份:2020
- 资助金额:
$ 58.25万 - 项目类别:
Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease
血浆鞘脂与亚临床和临床心血管疾病
- 批准号:
10403432 - 财政年份:2020
- 资助金额:
$ 58.25万 - 项目类别:
Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease
血浆鞘脂与亚临床和临床心血管疾病
- 批准号:
10646441 - 财政年份:2020
- 资助金额:
$ 58.25万 - 项目类别:
Circulating sphingolipids and risk and outcomes of ventricular fibrillation
循环鞘脂与心室颤动的风险和结果
- 批准号:
10186805 - 财政年份:2020
- 资助金额:
$ 58.25万 - 项目类别:
Plasma sphingolipids and risk of cardiovascular disease
血浆鞘脂与心血管疾病的风险
- 批准号:
9253248 - 财政年份:2016
- 资助金额:
$ 58.25万 - 项目类别:
Epoxyeicosatrienoic acids, diabetes, and cardiovascular disease
环氧二十碳三烯酸、糖尿病和心血管疾病
- 批准号:
9195147 - 财政年份:2015
- 资助金额:
$ 58.25万 - 项目类别:
Epoxyeicosatrienoic acids, diabetes, and cardiovascular disease
环氧二十碳三烯酸、糖尿病和心血管疾病
- 批准号:
9004661 - 财政年份:2015
- 资助金额:
$ 58.25万 - 项目类别:
Sphingolipids, Diabetes, and Cardiovascular Disease
鞘脂、糖尿病和心血管疾病
- 批准号:
9109632 - 财政年份:2014
- 资助金额:
$ 58.25万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 58.25万 - 项目类别:
Research Grant